Base of tongue squamous cell carcinoma with infiltrative bone marrow carcinomatosis after definitive chemoradiation: A case report

Head & Neck ◽  
2016 ◽  
Vol 38 (7) ◽  
pp. E2449-E2453 ◽  
Author(s):  
Kaitlin Christopherson ◽  
David N. Reisman ◽  
Kristianna Fredenburg ◽  
Reordan DeJesus ◽  
William M. Mendenhall
Keyword(s):  
Bone Marrow ◽  
Squamous Cell Carcinoma ◽  
Case Report ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Tongue Squamous Cell Carcinoma ◽  
Base Of Tongue ◽  
Definitive Chemoradiation

Radiotherapy alone or combined with chemotherapy for base of tongue squamous cell carcinoma

2017 ◽  
Vol 127 (7) ◽  
pp. 1589-1594 ◽  
Author(s):  
Kaitlin Christopherson ◽  
Christopher G. Morris ◽  
Jessica M. Kirwan ◽  
Robert J. Amdur ◽  
Peter T. Dziegielewski ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Tongue Squamous Cell Carcinoma ◽  
Base Of Tongue ◽  
Radiotherapy Alone

Association of polymorphisms in genes related to cell cycle (ERP29, LEF1, MCC and PTCH1) and DNA transcription factors (IKBKAP and ZNF415) with base of tongue squamous cell carcinoma risk.

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 6073-6073
Author(s):  
Carmen Silvia Passos Lima ◽  
Benilton Carvalho ◽  
Renata Pellegrino ◽  
Leticia Khater ◽  
Carlos Takahiro Chone ◽  
...  
Keyword(s):  
Cell Cycle ◽  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Dna Microarrays ◽  
Tongue Squamous Cell Carcinoma ◽  
Nucleotide Polymorphisms ◽  
Dna Transcription ◽  
Base Of Tongue ◽  
First Time

6073 Background: Recently, we found 6.609 genetic single nucleotide polymorphisms (SNPs) with distinct frequencies between base of tongue squamous cell carcinoma (BTSCC) patients and controls. The study was performed using high-resolution DNA microarrays genotyping (Affymetrix). The SNPs identified never have been previously described with BTSCC risk. Some SNPs of interest were located in genes related to cell cycle (ERP29, LEF1, MCC and PTCH1) and DNA transcription (IKBKAP and ZNF415) and they were selected to validation process. Objective: Validate the SNPs ERP29 c.*293A>G (rs7114); LEF1 c.*1213A>G (rs2107028) and g.127267A>G (rs4245926); MCC c.*5077A>G (rs7033); PTCH1 g.27369025G>A (rs16909856) and g.27369324G>A (rs16909859); IKBKAP c.3214T>A (rs3204145) and ZNF415 c.*443A>G (rs3814) associated to BTSCC risk. Methods: Genomic DNA from 49 BTSCC patients and 49 controls was genotyping by TaqMan assays (Applied Biosystems). The differences between groups were analyzed by logistic regression model. Power analysis (PA) was used to verify the effect of sample size on the results obtained. Results: Eight SNPs identified by Affymetrix were validated by TaqMan assays. The frequencies of ERP29 c.*293AG+GG (30 vs 11%, P=0.03; PA=65%), LEF1 c.*1213AA+AG (95 vs 80%, P=0.02; PA=61%) and g.127267AA+AG (93 vs 78%, P=0.02; PA=56%), MCC c.*5077AA+AG (85 vs 64%, P=0.008; PA=67%), PTCH1 g.27369025GG+GA (90 vs 73%, P=0.005; PA=58%) and g.27369324GG+GA (90 vs 73%, P=0.008; PA=58%), IKBKAP c.3214TT+TA (90 vs 72%, P=0.01; PA=62%) and ZNF415 c.*443AA+AG (59 vs 41%, P=0.02; PA=43%) were more common in patients than in controls. Individuals with these genotypes were at 2.9(CI95%: 1.1-8.4), 3.9 (CI95%: 1.4-11.2), 4.0 (CI95%: 1.2-14.7), 3.5 (CI95%: 1.2-11.9), 5.0 (CI95%: 1.7-16.9), 4.5 (CI95%: 1.5-15.2), 4.1 (CI95%: 1.4-12.9), and 3.9 (CI95%: 1.2-13.7)-fold increased risks for BTSCC than others, respectively. Conclusions: Our data present for the first time evidence that inherited abnormalities in ERP29, MCC, LEF1, PTCH1, IKBKAP, and ZNF415 genes may be important determinants of BTSCC. Financial support: FAPESP and FINEP.

scholarly journals Long-term Survival Outcome in Transhyoid Resection of Base of Tongue Squamous Cell Carcinoma

2002 ◽  
Vol 128 (9) ◽  
pp. 1067 ◽  
Author(s):  
Babak Azizzadeh ◽  
Pedram Enayati ◽  
Dinesh Chhetri ◽  
Ellie Maghami ◽  
Babak Larian ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Survival Outcome ◽  
Tongue Squamous Cell Carcinoma ◽  
Term Survival ◽  
Long Term Survival ◽  
Base Of Tongue

scholarly journals Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma

Viruses ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 910
Author(s):  
Anders Näsman ◽  
Stefan Holzhauser ◽  
Ourania N. Kostopoulou ◽  
Mark Zupancic ◽  
Andreas Ährlund-Richter ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Human Papillomavirus ◽  
Targeted Therapy ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Disease Free Survival ◽  
Tongue Squamous Cell Carcinoma ◽  
Patient Treatment ◽  
Cancer Genes ◽  
Base Of Tongue

The incidence of Human-papillomavirus-positive (HPV+) tonsillar and base-of-tongue squamous cell carcinoma (TSCC and BOTSCC, respectively) is increasing epidemically, but they have better prognosis than equivalent HPV-negative (HPV−) cancers, with roughly 80% vs. 50% 3-year disease-free survival, respectively. The majority of HPV+ TSCC and BOTSCC patients therefore most likely do not require the intensified chemoradiotherapy given today to head and neck cancer patients and would with de-escalated therapy avoid several severe side effects. Moreover, for those with poor prognosis, survival has not improved, so better-tailored alternatives are urgently needed. In line with refined personalized medicine, recent studies have focused on identifying predictive markers and driver cancer genes useful for better stratifying patient treatment as well as for targeted therapy. This review presents some of these endeavors and briefly describes some recent experimental progress and some clinical trials with targeted therapy.

Sign in / Sign up

Export Citation Format

Share Document